Aytu BioPharma Inc. (AYTU) Income Statement Analysis - Revenue, Earnings & Profitability Metrics - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    Aytu BioPharma Inc.

    NASDAQ: AYTU · Real-Time Price · USD
    2.27
    0.02 (0.89%)
    At close: Sep 08, 2025, 3:59 PM
    2.28
    0.66%
    After-hours: Sep 08, 2025, 05:29 PM EDT

    Aytu BioPharma Income Statement

    Financials in USD. Fiscal year is July - June.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Jun 30, 2024 Jun 30, 2023 Jun 30, 2022 Jun 30, 2021
    Revenue
    		 81M 107.4M 96.67M 65.63M
    Cost of Revenue
    		 31.63M 40.77M 44.39M 36.43M
    Gross Profit
    		 49.37M 66.63M 46.44M 29.2M
    Operating Income
    		 -5.25M -17.07M -109.91M -58.87M
    Interest Income
    		 n/a 9K 14K 6K
    Pretax Income
    		 -14.08M -17.05M -108.89M -58.03M
    Net Income
    		 -15.84M -17.05M -108.78M -58.29M
    Selling & General & Admin
    		 49.47M 70.08M 69.88M 55.81M
    Research & Development
    		 2.79M 4.09M 14.44M 5.62M
    Other Expenses
    		 8.31M 9.52M 77.87M 6.01M
    Operating Expenses
    		 60.57M 83.7M 162.19M 67.44M
    Interest Expense
    		 4.79M 4.96M 147.5M n/a
    Selling & Marketing Expenses
    		 26.96M 41.45M 38.71M 30.31M
    Cost & Expenses
    		 86.26M 124.46M 206.57M 124.5M
    Income Tax Expense
    		 1.77M -57K -110K 259K
    Shares Outstanding (Basic)
    		 5.54M 3.34M 1.47M 840K
    Shares Outstanding (Diluted)
    		 5.54M 3.34M 1.47M 840K
    EPS (Basic)
    		 -2.86 -5.11 -74.01 -69.6
    EPS (Diluted)
    		 -2.86 -5.11 -74.01 -69.6
    EBITDA
    		 -1.01M -3.27M -98.74M -29.04M
    EBIT
    		 -9.28M -12.09M -108.89M -38.24M
    Depreciation & Amortization
    		 8.27M 8.81M 10.15M 9.2M

    Add to Watchlist